RNA medicines for liver diseases
Company is active
Event Year: 2020
Company is active
Event Year: 2020
Ochre Bio is a pioneering biotechnology firm dedicated to the development of innovative RNA-based therapeutics specifically designed to combat chronic liver diseases. By leveraging the power of RNA medicine, Ochre Bio aims to address the unmet medical needs of patients suffering from a range of debilitating liver conditions. The company is committed to advancing scientific research and translating discoveries into effective treatments that improve patient outcomes and transform the landscape of liver disease management.
Ochre Bio is a pioneering biotechnology firm dedicated to the development of innovative RNA-based therapeutics specifically designed to combat chronic liver diseases. By leveraging the power of RNA medicine, Ochre Bio aims to address the unmet medical needs of patients suffering from a range of debilitating liver conditions. The company is committed to advancing scientific research and translating discoveries into effective treatments that improve patient outcomes and transform the landscape of liver disease management.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2020
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 50
Hiring: No
Team size: 50
Hiring: No
